Celyad completes follow-on

Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Business: Gene/Cell therapy, Cardiovascular, Cancer Date completed: 2015-06-18 Type: Follow-on Raised: $80.1 million Shares: 1.2 m...